Researchers sought to determine whether combination therapy with zanubrutinib, obinutuzumab, and venetoclax would be effective for TP53-mutant MCL.

A financial toxicity tumor board has effectively reduced financial toxicity for cancer patients, researchers say.

An analysis of 10 cancer treatment sites revealed that many pediatric patients do not receive care pathway-consistent and CPG-consistent care.

This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

HealthDay News — Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal ...

Consensus statements on managing childhood dystonia were recently released by a panel of experts in pediatric palliative care.

The Fatigue Scale provides a reliable measure of fatigue in most populations of pediatric patients with cancer.

Registered nurse shift length and skill level mix in the previous 7 days influence sickness-related absences in nurse and nursing support staff.

This road map to building a high-performance nursing team is a key component in health system’s efforts to expand cancer care ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

To develop the combined model, the researchers integrated the imaging-derived radiomics score from the best-performing radiomics model (random forest) with the clinical model.

The cohort study included more than a quarter million men with prostate cancer from routine clinical practice.